The data of the TCGA database demonstrated that those PCa patients who showed low SERPINB5 and high BIRC5 transcript expression were characterized by a reduced disease-free survival rate, thereby highlighting the clinical relevance of the activation of the NFκB pathway in human prostate cancer. Here, BIRC5 is linked to prostate carcinoma.